Patrick Johnson

Nov 20, 2024 | cdp.cooley.com | Patrick Johnson

On November 9, 2024, the five-person board of the California Privacy Protection Agency (CPPA) voted unanimously to adopt the proposed Data Broker Registration regulations without modifications. The new regulations seek to clarify key provisions of the California Delete Act, which requires data brokers to register with the state of California and the CPPA to establish a universal data deletion mechanism by January 1, 2026.

May 1, 2024 | jdsupra.com | Andrew Hockley |Patrick Johnson

On 10 April 2024, Australia’s Federal Government announced far-reaching reforms to its merger control regime, most notably the introduction of a new single, mandatory and suspensory, merger control system. The reform package is due to come into effect from 1 January 2026 and will align Australia’s regime for reviewing M&A transactions from a competition perspective with the majority of other merger control regimes globally.

Apr 1, 2024 | mondaq.com | Robert Wagman Jr. |Patrick Johnson |Daniel E. Hemli

Mergers and acquisitions involving companies that conduct business with the federal government present a unique set of challenges. Several statutes and regulations are implicated in such corporate transactions, whether the federal government is a company's smallest customer or its only customer. On March 18, 2024, U.S. Senators Elizabeth Warren (D-Mass.) and Mike Rounds (R-S.D.) sent a letter to the Secretary of Defense suggesting additional hurdles that may soon be put in place.

Mar 26, 2024 | jdsupra.com | Daniel E. Hemli |Patrick Johnson |Robert Wagman Jr.

Mergers and acquisitions involving companies that conduct business with the federal government present a unique set of challenges. Several statutes and regulations are implicated in such corporate transactions, whether the federal government is a company’s smallest customer or its only customer. On March 18, 2024, U.S. Senators Elizabeth Warren (D-Mass.) and Mike Rounds (R-S.D.) sent a letter to the Secretary of Defense suggesting additional hurdles that may soon be put in place.

Mar 4, 2024 | healio.com | Christina K. Ullrich |Patrick Johnson |Mindy Valcarcel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adoptive cellular therapies such as chimeric antigen receptor T-cell therapy have transformed the landscape of care for patients with relapsed or refractory hematologic malignancies.